Mounjaro (tirzepatide), a new drug for Type 2 Diabetes by Eli Lilly
FDA approved this novel, dual-targeted treatment for type 2 diabetes. The manufacturer reported that this drug proved more effective in clinical trials than other therapies evaluated. This injection could improve blood sugar control in adults with type 2 diabetes who practise diet and exercise. Mounjaro was effective at improving blood sugar and was more effective …
Mounjaro (tirzepatide), a new drug for Type 2 Diabetes by Eli Lilly Read More »